Date published: 2026-4-20

1-800-457-3801

SCBT Portrait Logo
Seach Input

PSTAIRE peptide

0.0(0)
Write a reviewAsk a question

Application:
PSTAIRE peptide is a biologically active peptide
Purity:
≥93%
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

PSTAIRE peptide is a synthetic oligopeptide derived from a highly conserved sequence found in the cyclin-dependent kinases (CDKs), a family of protein kinases pivotal in regulating cell cycle progression. The PSTAIRE motif, named after its sequence, is essential for binding with cyclin molecules, which is a critical step in the activation of CDKs. Research on this peptide has primarily focused on its role as a tool to disrupt CDK-cyclin interactions, thereby serving as a model to study the regulation and mechanistic pathways of cell cycle control. Studies using the PSTAIRE peptide have explored its potential to inhibit CDK activity by competing with natural CDK substrates for cyclin binding, which aids in understanding the dynamics of cell cycle regulation in various cell types. This peptide has also been instrumental in in vitro experiments designed to explain the structural requirements for cyclin recognition and the subsequent activation of CDKs. By blocking the PSTAIRE region, researchers can mimic conditions of CDK dysfunction, thereby contributing insights into cellular responses to impaired cell cycle progression, such as cell cycle arrest, apoptosis, or altered cellular metabolism. These investigations underscore the utility of PSTAIRE peptide in fundamental research aimed at decoding the cellular and molecular mechanisms governing cell division and its regulation.


PSTAIRE peptide References

  1. Cyclin-dependent kinases: a new cell cycle motif?  |  Pines, J. and Hunter, T. 1991. Trends Cell Biol. 1: 117-21. PMID: 14731542
  2. Development of a monoclonal antibody to the conserved region of p34cdc2 protein kinase.  |  Kamo, K., et al. 1992. J Immunol Methods. 156: 163-70. PMID: 1474253
  3. Regulation of synthesis of p34cdc2 and its homologues and their relationship to p110Rb phosphorylation during cell cycle progression of normal human T cells.  |  Lucas, JJ., et al. 1992. J Immunol. 148: 1804-11. PMID: 1541821
  4. Electrostatic control of peptide side-chain reactivity using amphiphilic homopolymer-based supramolecular assemblies.  |  Wang, F., et al. 2013. J Am Chem Soc. 135: 14179-88. PMID: 23971726
  5. A family of trypanosome cdc2-related protein kinases.  |  Mottram, JC. and Smith, G. 1995. Gene. 162: 147-52. PMID: 7557404
  6. Alteration of the phosphorylation state of p34cdc2 kinase by the flavone L86-8275 in breast carcinoma cells. Correlation with decreased H1 kinase activity.  |  Worland, PJ., et al. 1993. Biochem Pharmacol. 46: 1831-40. PMID: 8250970
  7. Association between p34cdc2 levels and meiotic arrest in pig oocytes during early growth.  |  Hirao, Y., et al. 1995. Zygote. 3: 325-32. PMID: 8730897
  8. Cloning of a cdc2-related protein kinase from Trypanosoma cruzi that interacts with mammalian cyclins.  |  Gómez, EB., et al. 1998. Mol Biochem Parasitol. 91: 337-51. PMID: 9580532

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

PSTAIRE peptide, 0.5 mg

sc-3142
0.5 mg
$96.00